Zynex, Inc. (ZYXI) Earnings Call Analysis
NASDAQ · Healthcare · Medical Distribution
Earnings Reports
-
Sinex (ZYXI) Q3 2025: Revenue Falls 73% as TRICARE Suspension and Cash Burn Force Strategic Reset
November 18, 2025
-
Zynex (ZYXI) Q2 2025: $40M Expense Reduction Reshapes Cost Structure Amid Revenue Hit
July 31, 2025
-
Zynex (ZYXI) Q1 2025: TRICARE Suspension Drives 43% Revenue Drop, Restructuring Targets $35M Cost Savings
July 07, 2025